{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:00Z","timestamp":1792664100713,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1124\/jpet.111.179416","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T19:08:39Z","timestamp":1300216119000},"page":"755-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Behavioral and Cellular Modulation of l-DOPA-Induced Dyskinesia by \u03b2-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat"],"prefix":"10.1016","volume":"337","author":[{"given":"David","family":"Lindenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne Y.","family":"Ostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Eskow Jaunarajs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin B.","family":"Dupre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Barnum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Bhide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.179416_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord"},{"key":"10.1124\/jpet.111.179416_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/syn.20535","article-title":"Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson\u2019s disease via norepinephrine transporter","volume":"62","author":"Arai","year":"2008","journal-title":"Synapse"},{"key":"10.1124\/jpet.111.179416_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2008.07.016","article-title":"Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta","volume":"156","author":"Barnum","year":"2008","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.111.179416_bib4","doi-asserted-by":"crossref","first-page":"14845","DOI":"10.1073\/pnas.1009874107","article-title":"Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors","volume":"107","author":"Bateup","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.179416_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0022-3565(25)32235-4","article-title":"Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat","volume":"214","author":"Bianchetti","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179416_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.111.179416_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/jpet.104.066365","article-title":"Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A\/2C agonism","volume":"310","author":"Bishop","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179416_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.20612","article-title":"Nondopaminergic mechanisms in levodopa-induced dyskinesia","volume":"20","author":"Brotchie","year":"2005","journal-title":"Mov Disord"},{"key":"10.1124\/jpet.111.179416_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1471-4159.2009.06482.x","article-title":"The \u03b12 adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats","volume":"112","author":"Buck","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.179416_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/syn.20709","article-title":"The selective \u03b11 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"64","author":"Buck","year":"2010","journal-title":"Synapse"},{"key":"10.1124\/jpet.111.179416_bib11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.46.6.1548","article-title":"Improvement of levodopa-induced dyskinesia by propranolol in Parkinson\u2019s disease","volume":"46","author":"Carpentier","year":"1996","journal-title":"Neurology"},{"key":"10.1124\/jpet.111.179416_bib12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"key":"10.1124\/jpet.111.179416_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.111.179416_bib14","first-page":"2694","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.111.179416_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0925s41","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson\u2019s disease in rats and mice","author":"Cenci","year":"2007","journal-title":"Curr Protoc Neurosci"},{"key":"10.1124\/jpet.111.179416_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson\u2019s disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.111.179416_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00002826-200311000-00008","article-title":"Noradrenergic drugs for levodopa-induced dyskinesia","volume":"26","author":"Colosimo","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/jpet.111.179416_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.111.179416_bib19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.neuropharm.2008.08.031","article-title":"Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat","volume":"55","author":"Dupre","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.179416_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/syn.20630","article-title":"The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats","volume":"63","author":"Eskow","year":"2009","journal-title":"Synapse"},{"key":"10.1124\/jpet.111.179416_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","article-title":"The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy","volume":"87","author":"Eskow","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.111.179416_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1124\/jpet.111.179416_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00002826-199310000-00004","article-title":"Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys","volume":"16","author":"Gomez-Mancilla","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/jpet.111.179416_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0021-5198(19)39981-0","volume":"55","author":"Goshima","year":"1991","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/jpet.111.179416_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1471-4159.2010.06668.x","article-title":"Role of adrenoceptors in the regulation of dopamine\/DARPP-32 signaling in neostriatal neurons","volume":"113","author":"Hara","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.179416_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/jpet.111.179416_bib27","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1471-4159.1986.tb08506.x","article-title":"A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation","volume":"46","author":"Kilpatrick","year":"1986","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.179416_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.111.179416_bib29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/0006-2952(82)90668-2","article-title":"Effects of propranolol and a number of its analogues on sodium channels","volume":"31","author":"Matthews","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179416_bib30","first-page":"185","article-title":"Stereospecific pharmacokinetics and pharmacodynamics of \u03b2-adrenergic blockers in humans","volume":"4","author":"Mehvar","year":"2001","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/jpet.111.179416_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-2999(84)90173-0","article-title":"Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol","volume":"101","author":"Middlemiss","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.179416_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2007.01.002","article-title":"Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson\u2019s disease","volume":"254","author":"Oka","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1124\/jpet.111.179416_bib33","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1124\/jpet.111.179416_bib34","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.81.5.1585","article-title":"Quantitative autoradiography of \u03b21- and \u03b22-adrenergic receptors in rat brain","volume":"81","author":"Rainbow","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.179416_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-8993(82)91235-5","article-title":"A role for striatal beta-adrenergic receptors in the regulation of dopamine release","volume":"241","author":"Reisine","year":"1982","journal-title":"Brain Res"},{"key":"10.1124\/jpet.111.179416_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","article-title":"Norepinephrine: The redheaded stepchild of Parkinson\u2019s disease","volume":"74","author":"Rommelfanger","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179416_bib37","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.179416_bib38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mds.10464","article-title":"Fipamezole (JP-1730) is a potent \u03b12 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson\u2019s disease","volume":"18","author":"Savola","year":"2003","journal-title":"Mov Disord"},{"key":"10.1124\/jpet.111.179416_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/syn.890080405","article-title":"\u03b2-Adrenergic receptor subtypes in the basal ganglia of patients with Huntington\u2019s chorea and Parkinson\u2019s disease","volume":"8","author":"Waeber","year":"1991","journal-title":"Synapse"},{"key":"10.1124\/jpet.111.179416_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol Dis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524463969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524463969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.179416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:30:38Z","timestamp":1740018638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524463969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0022356524463969"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.179416","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral and Cellular Modulation of l-DOPA-Induced Dyskinesia by \u03b2-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.179416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}